Local Manufacturing Takes Center Stage – Kenya‘s 2026–2030 Strategy Reshapes Africa’s Medical Supply Chain

In June 2026, Kenya officially launched its Health Products and Technologies Local Manufacturing Strategy 2026–2030, a five-year roadmap to expand local production of medicines, vaccines, diagnostics, and medical devices. This marks a pivotal moment in Africa‘s pursuit of health sovereignty and has far-reaching implications for medical trade.

The Scale of Import Dependence

Kenya’s health products market is worth approximately US$1.2 billion annually, with more than US$760 million spent on imports. The country still imports an estimated 70 to 80% of the pharmaceuticals it consumes – a reliance that left the country exposed when COVID-19 and mpox outbreaks disrupted global supply chains. Locally, manufacturers produce only around 20% of the medicines on Kenya‘s Essential Medicines List.

The Strategy‘s Ambitions

The new strategy aims to lift utilisation of existing manufacturing capacity by 70% by 2030, help manufacturers reach internationally recognised Good Manufacturing Practice standards, and introduce multi-year procurement commitments. Kenya is already the third-largest exporter of pharmaceutical products in Africa and the largest supplier within COMESA, holding close to half that regional market

On the vaccines front, Kenya joined the WHO-Medicines Patent Pool mRNA Technology Transfer Programme in February 2026, with the Kenya BioVax Institute building local capacity to manufacture vaccines against COVID-19, malaria, tuberculosis, and other outbreak-prone diseases.

What This Means for Medical Trade

For foreign medical equipment and consumables suppliers, Kenya‘s local manufacturing push presents both challenges and opportunities:

• Short-term: Import demand for basic consumables and essential medicines may gradually be replaced by local production.

• Medium to long-term: New opportunities emerge in supplying production equipment, testing instruments, raw materials, and intermediate goods.

• Service opportunities: African manufacturers need professional support in technology transfer, quality control, GMP certification, and product registration.

As WHO Representative a.i. to Kenya Dr Neema Rusibamayila Kimambo stated: “As Kenya expands local manufacturing, quality must remain at the centre of every step of the journey”. This is where experienced trade service providers can add value – helping both Chinese equipment suppliers reach African manufacturers and African producers access the right technology and components.